India's Ind-Swift Laboratories Ltd. appointed Poonam Maini an independent director of the company.
Ind-Swift develops active pharmaceutical ingredients, which are used in the manufacturing of medicines.
Ind-Swift Laboratories adds independent director
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective
Ind-Swift Laboratories adds independent director
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals